Lactulose is a synthetic disaccharide widely used in clinical medicine, primarily for the treatment of constipation and hepatic encephalopathy. Discovered in the 1950s, this agent has since become a cornerstone in managing conditions involving altered ammonia metabolism and bowel motility.
Unlike most sugars, lactulose is not absorbed in the small intestine, which lends it unique pharmacologic properties. It is categorized as an osmotic laxative and a prebiotic agent. Its safety profile and efficacy have made it a preferred option in both acute and chronic treatment settings.
Chemical Structure
Lactulose is a synthetic sugar composed of one molecule each of galactose and fructose, linked by a β-1,4 glycosidic bond. Its IUPAC name is 4-O-β-D-Galactopyranosyl-D-fructose, and its molecular formula is C12H22O11 with a molecular weight of 342.30 g/mol. Structurally, it resembles other disaccharides, but its resistance to digestion in the small intestine sets it apart. It is typically derived from lactose via an isomerization process under alkaline conditions.
Lactulose-Based Medicines
The following are the most commonly prescribed or available medications containing lactulose:
| Brand Name | Formulation |
|---|---|
| Duphalac® | Oral syrup |
| Lactulax® | Oral solution |
| Constulose® | Oral syrup |
| Kristalose® | Oral powder packets |
| Generlac® | Oral syrup |
| Enulose® | Oral solution |
| Chronulac® | Oral syrup |
| Laxilose® | Oral syrup/tablets |
These formulations are available under various brand names globally, with minor variations in inactive ingredients or concentration.
Mechanism of Action
Lactulose exerts its effect primarily in the large intestine, where it undergoes fermentation by colonic bacteria. This fermentation produces short-chain fatty acids (SCFAs) such as lactic acid and acetic acid, which lower the colonic pH. The acidic environment suppresses ammonia-producing bacteria and promotes the conversion of ammonia (NH₃) to ammonium (NH₄⁺), which is less absorbable and can be excreted.
Additionally, the osmotic effect of unabsorbed lactulose draws water into the bowel lumen, softening stools and stimulating peristalsis, thereby acting as a laxative. It also promotes the growth of beneficial bacteria such as Bifidobacteria and Lactobacilli, hence its prebiotic classification.
Pharmacokinetics
Lactulose is poorly absorbed from the gastrointestinal tract and not metabolized by human enzymes. After oral administration:
- Absorption: Negligible in the small intestine.
- Metabolism: Colonic bacteria break it down into SCFAs and gases (hydrogen, methane).
- Onset of Action: 24–48 hours for laxative effect; longer for hepatic encephalopathy benefits.
- Excretion: Primarily through feces; unfermented “lactulose “may be excreted unchanged.
This unique profile results in minimal systemic absorption and low risk of systemic side effects.
Therapeutic Uses
Lactulose has a broad range of indications. Its primary and secondary therapeutic applications are summarized below:
| Indication | Description/Use |
|---|---|
| Constipation | Chronic idiopathic or opioid-induced constipation, especially in the elderly. |
| Hepatic Encephalopathy (HE) | Prevention and treatment of HE by reducing systemic ammonia levels. |
| Portal-systemic Encephalopathy | Long-term management in cirrhotic patients with recurrent encephalopathy. |
| Bowel Preparation | Occasionally used prior to colonoscopy. |
| Probiotic Support | Encourages beneficial gut flora. |
| Irritable Bowel Syndrome (IBS) | May aid in symptom relief in constipation-predominant IBS. |
| Hyperammonemia in Children | Off-label use in pediatric inborn errors of metabolism. |
| Colonic pH Reduction | Used experimentally for altering pH-dependent drug absorption or flora balance. |
Side Effects
Lactulose is generally well-tolerated, especially with dose titration. However, some side effects may occur, particularly in higher doses:
- Gastrointestinal: Bloating, flatulence, abdominal cramps, nausea, and diarrhea (most common).
- Metabolic: Electrolyte imbalances such as hypokalemia and hypernatremia may occur with prolonged use.
- Allergic Reactions: Rare, but may include rash or itching.
- Dehydration: Possible if fluid intake is not maintained during therapy.
Side effects are usually dose-dependent and reversible upon dose reduction or discontinuation.
Drug Interactions
Lactulose has minimal systemic absorption, reducing its potential for systemic drug interactions. However, notable interactions include:
- Antacids: May neutralize the acidic environment required for lactulose’s action.
- Other Laxatives: Concurrent use may exacerbate fluid loss and electrolyte disturbances.
- Neomycin: Used together in severe hepatic encephalopathy but requires close monitoring for toxicity.
- Warfarin: Altered gut flora may theoretically affect vitamin K synthesis, influencing INR levels.
- Oral Antibiotics: Broad-spectrum antibiotics can reduce lactulose efficacy in hepatic encephalopathy by altering gut flora.
Safety Considerations
Lactulose is considered safe for use in most populations, including:
- Pregnancy: Category B (no evidence of harm in humans). Often used for constipation in pregnancy.
- Lactation: Minimal excretion in breast milk; considered safe.
- Pediatrics: Used cautiously and under supervision, especially in hepatic disorders.
- Elderly: Safe, though careful dose titration is needed to avoid dehydration or diarrhea.
Contraindications include patients with galactosemia (due to galactose content) or known hypersensitivity. Use cautiously in diabetics due to carbohydrate load, especially in syrup formulations.
Regulatory Status
Lactulose is approved by numerous health authorities worldwide:
- U.S. FDA: Approved for hepatic encephalopathy and constipation.
- EMA (Europe): Widely used with country-specific trade names and indications.
- WHO: Listed in the World Health Organization’s Model List of Essential Medicines.
- Over-the-Counter (OTC): Available without a prescription in some countries, particularly for constipation.
It is typically marketed as a syrup (e.g., 10g/15mL), powder sachets, or oral solutions and is regulated as a prescription or OTC drug depending on the jurisdiction and indication.
Conclusion
Lactulose is a versatile and well-established pharmaceutical agent with broad applications in gastrointestinal and hepatic medicine. Its unique pharmacological profile—non-absorbable, fermentable, and prebiotic—makes it effective in treating conditions ranging from simple constipation to complex hepatic encephalopathy. Given its minimal systemic absorption, it boasts a favorable safety profile, even in vulnerable populations such as children and the elderly. Though not without side effects, its therapeutic value remains high, and its position in international formularies ensures continued clinical relevance.
